The expression of CD200 has been associated with the characteristics of cancer stem cells shown in head and neck squamous cell carcinomas, and also with the reduced chemosensitivity and radiosensitivity of these cancers [20]. The gene discussed is CD200; the disease is head and neck squamous cell carcinoma.